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1. The in vivo measurement of evoked extracellular dopamine was established in the
basolateral amygdaloid nucleus (BAN) using fast-scan cyclic voltammetry at carbon-
fibre microelectrodes.
2. The identification of evoked extracellular dopamine in the BAN was based on
anatomical, electrochemical and pharmacological criteria. Electrochemical and
pharmacological evidence indicated that the species was a catecholamine. Mesencephalic
sites eliciting overflow and amygdaloid sites supporting overflow correlated well with the
mesoamygdaloid dopamine innervation.
3. Marked differences in the dynamics and magnitude of evoked dopamine overflow were
observed in the BAN, caudate-putamen and amygdalo-striatal transition area. The
results underscore the importance of making spatially resolved measurements of
extracellular dopamine in the amygdala.
4. Mesoamygdaloid dopamine neurons have similar release characteristics as mesostriatal
dopamine neurons but share with mesoprefrontal cortical dopamine neurons the ability
to use a greater percentage of intraneuronal dopamine stores for release.
Dopamine is an important neurotransmitter in the
amygdala, a phylogenetically older structure of the brain
which is thought to play a critical role in limbic, cognitive
and neuroendocrine functions (De Olmos, Alheid &
Beltramino, 1985). The dopamine neurons innervating the
amygdala originate primarily in the substantia nigra and
ventral tegmental area (Fallon, 1988) although some
dopamine fibres originate in the thalamus (Takada, 1990).
Terminal fields for dopamine neurons are heterogeneously
distributed in the amygdala and high concentrations of
dopamine are found in the basolateral amygdaloid nucleus
(BAN), where the tissue content is approximately 6 times
less than in the striatum (Kilts & Anderson, 1987). In
addition, sites for dopamine uptake (Mennicken, Savasta,
Peretti-Renucci & Feuerstein, 1992), dopamine receptors
(Scibilia, Lachowica & Kilts, 1992) and synthetic and
degradative enzymes for dopamine (Saavedra & Zivin,
1976) have been localized to the amygdala.
The mesoamygdaloid dopamine neurons comprise part
of the mesotelencephalic dopamine system whose fibres
ascend from the ventral mesencephalon to different areas
of the telencephalon, including the basal ganglia and the
cortex. The mesostriatal and mesoprefrontal cortical
dopamine neurons are the best studied. In general,
biochemical, pharmacological and electrophysiological
evidence indicates that the functional characteristics of the
dopamine neurons innervating the caudate-putamen and
nucleus accumbens of the striatum are similar but distinct
from the dopamine neurons innervating the medial
prefrontal cortex (Bannon & Roth, 1983; Glowinski, Tassin
& Thierry, 1984; Garris, Collins, Jones & Wightman, 1993).
Although much less is known about mesoamygdaloid
dopamine neurons, there is some evidence to suggest that
these dopamine neurons are also unique. For example,
mesoamygdaloid dopamine neurons exhibit a fast turnover
rate for dopamine (Kilts & Anderson, 1987) and lack
autoreceptors governing dopamine synthesis (Kilts,
Anderson, Ely & Nishita, 1987), characteristics which more
resemble mesoprefrontal cortical rather than mesostriatal
dopamine neurons.
The advent of in vivo methodologies to monitor extra-
cellular dopamine concentrations, for example, push-pull
cannulae, microdialysis and voltammetry, has greatly
increased our understanding of dopamine regulation and
function in the brain. However, there are only a few
reports examining extracellular dopamine in the amygdala
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(see Discussion). One technical difficulty is that the amygdala
is comprised of many small nuclei whose function and
neurochemistry are not uniform. In addition, the
mesoamygdaloid dopamine innervation is not homogeneous
(Kilts, Anderson, Ely & Mailman, 1988). Thus, an important
consideration for the measurement of extracellular
dopamine in the amygdala is the spatial resolution of the
technique employed. Fast-scan cyclic voltammetry at
carbon-fibre microelectrodes enables the measurement of
extracellular dopamine levels in the brain with excellent
spatial resolution (Adams, 1990). This technique has
previously been used to monitor extracellular dopamine in
the caudate-putamen, nucleus accumbens and medial
prefrontal cortex (Millar, Stamford, Kruk & Wightman,
1985; Stamford, Kruk & Millar, 1988; Garris et al. 1993) and
provides the capability to determine evoked dopamine
overflow in vivo in spatial increments of less than 100 ,tm
(May & Wightman, 1989). Recently, we have kinetically
analysed overflow in the BAN evoked by medial forebrain
bundle stimulation and observed that uptake rates, when
normalized to dopamine terminal density, are at least 10
times slower than in the striatum or medial prefrontal
cortex (Garris & Wightman, 1994). In contrast, relative
release rates were 10 times higher in the medial prefrontal
cortex compared with the other regions. In this paper, we
provide complementary evidence that the signal measured
in the BAN is dopamine, and further characterize its
release. Unlike in the striatum, dopamine is not the
predominant catecholamine in the amygdala but is present
in tissue in similar concentrations to noradrenaline. This is
a major problem since both dopamine and noradrenaline
fibres traverse the medial forebrain bundle and
catecholamines cannot be electrochemically distinquished
with fast-scan cyclic voltammetry.
METHODS
Animals
Adult, male Sprague-Dawley rats (300-550 g) were purchased
from Charles Rivers (Wilmington, MA, USA). Food and water
were provided ad libitum. Animal protocols are in accordance
with the Guide for Care and Use of Laboratory Animals
(National Institutes of Health publication No. 865-23,
Besthesda, MD, USA) and approved by the Institutional
Animal Care and Use Committee of the University of North
Carolina.
Surgery
The surgical procedure is described in detail elsewhere (Garris
et al. 1993). Rats were anaesthetized with urethane (1P5 g kg')
administered intraperitoneally (i.P.), immobilized in a
stereotaxic apparatus and maintained at a temperature of
37 'C. Holes were drilled in the skull for reference, stimulating
and working electrodes. Flat skull stereotaxic co-ordinates are
given in millimetres relative to bregma and dura mater
according to the atlas of Paxinos & Watson (1986). For all
experiments, a working electrode was placed in the dorso-
medial caudate-putamen at +1P2 AP, +2-0 ML, 4 5-5 0 DV.
Usually, a second working electrode was directly placed in the
BAN at -2-3 AP, +4-8 ML, 7 5-9 0 DV. In other experiments,
the second working electrode was placed at -2-3 AP and
+4-8 ML, and lowered over the range of 5-0-10-0 DV
traversing the tail of the caudate-putamen, amygdalo-striatal
transition area and BAN. The stimulating electrode was
placed in the medial forebrain bundle (-40 AP, +1-4 ML,
7 5-9 0 DV) or the ventral tegmental area-substantia nigra
region (-5-6 AP, +0-8 ML, 7 5-9 0 DV).
Electrical stimulation
Electrical stimulation was optically isolated (NL 800,
Neurolog, Medical Systems Corp., Great Neck, NY, USA) from
the electrochemistry. Biphasic square-wave pulses (current
and duration of each phase were 300-350,uA and 2 ms,
respectively) were applied at a twisted bipolar electrode
(Plastics One, Roanoke, VA, USA). Stimulating electrodes
were insulated to the tips, which were 0-25 mm in diameter
and separated by 1 mm.
Electrochemistry
Cyclic voltammograms were recorded every 100 ms at a scan
rate of 300 Vs-' (-04 to 10V) using a dual potentiostat
(EJ-400, Ensman Instrumentation, Bloomington, IN, USA)
under computer control (Wiedemann, Kawagoe, Kennedy,
Ciolkowski & Wightman, 1991). The carbon-fibre (r =5,m)
microelectrodes were bevelled at 25 deg and coated with
Nafion (Baur, Kristensen, May, Wiedemann & Wightman,
1988). The reference electrode used in all cases was a sodium-
saturated calomel electrode (SSCE). Contact with the dura
mater was made using a salt bridge consisting of a pipette tip
stuffed with adsorbent paper and filled with 150 mm NaCl. The
time-dependent current was monitored over a potential range
encompassing the peak oxidation potential for dopamine in
successive voltammograms and converted to concentration
based on postcalibration of the working electrode with
dopamine in vitro.
Histology
Electrode placements were histologically verified in some
animals. After postcalibration, working electrodes were
re-lowered to their original position and a lesion was made at
the electrode tip by delivering a 10 s, 9 V pulse from a battery.
Rats were perfused with 0 7 % NaCl followed by 10 %
formalin. Whole brains were removed from the skull and
stored in 10 % formalin. At a later date (at least 1 month),
brains were sectioned into 100 ,um thick slices using a
vibratome (Lancer 1000, Technical Products International, St
Louis, MO, USA) and stained with 0-2 % thionin. An example
electrode placement in the BAN is shown in Fig. 1. The arrow
marks the lesion made at the tip of the carbon-fibre working
electrode. Electrode tracts leading to the lesion were not
always visible.
Data analysis
Where applicable, all measurements are reported as the
means + S.E.M. Significance testing employed one- and two-
way analysis of variance (ANOVA) or Student's t test as noted
(Sokal & Roth, 1981). The decrease in evoked dopamine
concentration as a result of synthesis inhibition using a-
methyl-para-tyrosine (aMpT) administration (Fig. 7) was best
fitted to a single exponential curve using Sigma Plot 4.02
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(Jandel Scientific, Corte Madera, CA, USA). Rates of dopamine
overflow (uM s-1) were calculated using linear regression.
Reagents
All chemicals were purchased from Sigma Chemical Co. (St
Louis, MO, USA), were reagent grade and used as received.
Solutions were prepared in doubly distilled, deionized water
(Mega Pure System, Corning Glasswork, Corning, NY, USA).
All drugs were dissolved in 150 mm NaCl. In vitro
electrochemical measurements were performed in a buffer
consisting of 150 mm NaCl and 20 mm Hepes at pH 7-4.
RESULTS
Identification of the evoked species in the
basolateral amygdaloid nucleus
Dorsoventral heterogeneity of evoked overflow
The dorsoventral heterogeneity of evoked overflow in the
striatoamygdaloid region is shown in Fig. 2; Fig. 2A shows
individual overflow curves and the approximate electrode
locations are shown in Fig. 2B. The lesion shown in Fig. 1 is
located in the ventral-lateral aspect of the BAN. In both
the tail of the caudate-putamen (5 0-7 0 DV) and BAN
(8-0-8-4 DV), overflow increased during the stimulation
and returned to baseline after cessation of the stimulation.
Figure 1. Histology of the carbon-fibre electrode
placement in the basolateral amygdaloid nucleus
Arrow points to the lesion made at the tip of the electrode.
See Methods for details and Fig. 2 for brain atlas.
However, the magnitude and dynamics of overflow appeared
different in the two regions. In this animal, no evoked
overflow was observed in the amygdalostriatal transition
area (7 5 DV) although this was not always the case (see
Fig. 6). No evoked overflow was observed at depths greater
than 9 0 DV (data not shown).
Average responses in the tail of caudate-putamen
(5 0 DV) and BAN (8-0 DV) are presented in Fig. 2C.
Statistical analysis revealed a significant (P < 0-01;
ANOVA) increase in concentration with time during
stimulation in both regions. However, comparison between
regions at the time points indicated on the overflow curve
for the tail of the caudate-putamen by the S.E.M. revealed
significant (Student's t test) differences as shown by the
asterisks. Concentrations at early time points were
significantly greater and concentrations at later time
points were significantly less in the tail of the
caudate-putamen compared to the BAN. Thus, the initial
rate of overflow, maximum overflow and the rate at which
overflow returned to baseline post-stimulation were less in
the latter region. The depths at which the characteristic
overflow curves attributed to the BAN were observed
varied between 7f5 and 9 0 DV in the animals examined.
One source of variability with respect to the dorsoventral
J. Physiol. 478.2 241
242 P. A. Garris an
locations of the overflow curve types could be the different
sizes of animals used. For example, the final dorsoventral
position of the stimulating electrode in the medial
forebrain bundle varied by 1P5 mm. However, the overall
range over which these characteristic curves were observed
corresponded well to the shape of the BAN, which is an
oval extending dorsoventrally almost 1 mm.
Electrochemical and pharmacological
characterization
Background-subtracted cyclic voltammograms recorded in
vivo in the tail of the caudate-putamen and BAN and in
vitro from dopamine are compared in Fig. 3A. Voltammo-
grams were similar and characteristic of a catecholamine
(Baur et al. 1988). Voltammograms indicating the detection
of a catecholamine were found for all overflow curves
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shown in this paper (data not shown). The increase in
current recorded in the BAN during medial forebrain
bundle stimulation and averaged over the oxidation
potential for dopamine is shown in Fig. 3B. No increase was
observed when current is averaged over the potential range
of 0-200 mV, where catecholamines are electrochemically
inactive. Evoked overflow in the BAN was completely
abolished after administration of aMpT (200 mg kg' I.P.;
Fig. 3B). This experiment was repeated in four rats with
similar results (see Fig. 7).
Selective stimulation of ascending catecholamine
fibres
The dorsoventral position of the stimulating electrode
affected the magnitude of evoked overflow in the dorsomedial
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Figure 2. Dorsoventral heterogeneity of evoked overflow in the tail of the caudate-putamen
(CP), amygdalo-striatal transition area (AStr) and the basolateral amygdaloid nucleus (BAN)
A, individual overflow curves collected at one electrode at different depths below dura (see the
numbers in millimetres displayed at the end of the curves) in the same rat. El, initiation and
termination of a 60 Hz, 2 s stimulation. The stimulating electrode was situated in the medial
forebrain bundle and was optimized to elicit maximum dopamine overflow in the dorsomedial
caudate-putamen measured at a second electrode (data not shown). B, mean data from 4 rats
collected at 5 0 DV in the tail of the caudate-putamen (a) and 8-0 DV in the BAN (b). The S.E.M. iS
shown for every sixth point. These points were statistically compared between the two regions using
Student's t test (*P < 0-05; **P < 0-01). C, approximate electrode positions (0) for the overflow
curves shown in A. Diagram modified from the atlas of Paxinos & Watson (1986) at an anteroposterior
location of -2-30 mm. GP, globus pallidus; CAN, central amygdaloid nucleus.
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evoked overflow in the two regions at different stimulating
electrode positions. The approximate locations of the
stimulating electrode are shown in Fig. 4B. No response
was elicited in either the dorsomedial caudate-putamen or
BAN when the stimulating electrode was lowered from 6-0
to 84 DV. The region traversed by the stimulating
electrode included the dorsal tegmental bundle
(6-0-6-5 DV), which contains ascending noradrenaline
neurons (Ungerstedt, 1971). Thus, noradrenaline released
from these fibres does not contribute to the voltammetric
measurement of evoked overflow in the BAN or
dorsomedial caudate-putamen. In both the dorsomedial
caudate-putamen and BAN, evoked overflow (1) first
appeared when the stimulating electrode was lowered to
8-5DV, (2) reached a peak response at 8-8DV, and (3)
decreased after 8-8DV. These depths correspond to the
dorsoventral locations of the ventral tegmental area and
the substantia nigra. A similar relationship was observed
with medial forebrain bundle stimulation (data not shown).
However, some mesoamygdaloid dopamine neurons appear
to be located more dorsal than mesostriatal dopamine
neurons since the percentage maximum overflow was
initially higher in the BAN.
A
Average responses comparing evoked overflow in the
BAN elicited by stimulation of the ventral tegmental
area-substantia nigra or medial forebrain bundle are
shown in Fig. 4C. There was no statistical (ANOVA) effect
of stimulating region on the overflow curves. The location
of the measurements taken in the BAN ranged from 7f5 to
8f9 DV but did not include 8-0 DV. Note that the
characteristics of the average overflow curves shown in
Fig. 4 were remarkably similar to the curve shown in
Fig. 3, which was collected at 8-0 DV. These results suggest
that the dynamics of evoked overflow are homogeneous
throughout the BAN.
Comparison of evoked dopamine overflow in
the dorsomedial and tail of the
caudate-putamen and basolateral amygdaloid
nucleus
The dynamics and maximum concentration of overflow
evoked at frequencies between 20 and 60 Hz were similar in
both regions of the caudate-putamen (Fig. 5B). At 60 Hz,
overflow increased throughout the duration of the
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Figure 3. Electrochemical and pharmacological characterization of evoked overflow in the
basolateral amygdaloid nucleus
A, background subtracted cyclic voltammograms collected in vivo in the tail of the caudate-putamen
(CPt.,1; dashed line) and BAN (continuous line) of the same rat, and in vitro from dopamine (DA; 0).
Voltammograms were collected at the same electrode and were normalized to peak oxidation
current. Current (I) = 1P58, 0-26 and 0-20 nA for dopamine, the caudate-putamen and the BAN,
respectively. B, individual overflow curves in the BAN evoked by electrical stimulation of the medial
forebrain bundle for 2 s at 60 Hz. Traces shown as the continuous and short dashed lines are before
and after administration of aMpT (200 mg kg'), respectively, collected in the same rat; current was
monitored over the potential range of 500-700 mV. The trace shown as the long dashed line is the
same recording as the continuous line but current was monitored over the potential range of
0-200 mV. The trace showing the effects of aMpT treatment was recorded after an experiment
represented in Fig. 7B. [, initiation and termination of stimulation.
J. Physiol. 478.2 243
244 P. A. Garris anc
during stimulation at 20 Hz. The frequency dependence of
evoked dopamine overflow was present in the BAN
(Fig. 5A) but was not as pronounced. In addition, overflow
did not reach steady state at 20 Hz.
Release characteristics of mesoamygdaloid
dopamine neurons
Evoked dopamine overflow measured in the dorsomedial
caudate-putamen and BAN, and elicited by a
supraphysiological stimulation (60 Hz for 10 s), is compared
in Fig. 6. In both regions, the rate of overflow was not
constant during the period of stimulation but rather
decreased towards the end of the stimulation. The ratio of
linear overflow rates calculated for the last and first 5 s of
the stimulation was 0-32 + 0.05 (n= 9) in the BAN, and is
similar to that previously observed in the dorsomedial
caudate-putamen and nucleus accumbens (Garris et al.
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present in the amygdalo-striatal transition area when a
signal was observed here (Fig. 6, inset). However, these
responses were elicited by a 60 Hz stimulation for 2 s. In
addition, these responses appeared quite different from
those in either the caudate-putamen or BAN (Figs 2 and 5)
when elicited by an identical stimulation.
The time-dependent decline in the stimulated overflow of
dopamine after aMpT administration (200 mg kg' i.P.) is
shown for the BAN in Fig. 7. Individual overflow curves
collected in a representative animal are shown in Fig. 7A and
the average decline in maximum dopamine concentrations
is compiled in Fig. 7B. Two trains of this supraphysiological
stimulation delivered 20 min apart elicited similar concen-
trations of dopamine in the BAN. However, a decrease was
clearly observed immediately after administration of
ocMpT. The decay in maximum dopamine concentrations
fits a first-order exponential decay (continuous line,
Fig. 7B) with a rate constant of 1'4 + 0 1 h1 (n = 4).
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Figure 4. Selective activation of ascending catecholamine tracts
A, evoked overflow measured simultaneously in the basolateral amygdaloid nucleus (BAN; *) and
dorsomedial caudate-putamen (CP; 0). Voltammetric electrodes were placed at 7 5 and 4-5 DV in the
BAN and caudate-putamen, respectively. These positions were not changed during the experiment.
A stimulating electrode was lowered through the mesencephalon in 100 /am increments over a range
of 6-0 to 8-9 DV. A 60 Hz, 2 s stimulation was applied at each position. Stimulations were applied
5 min apart. Data are from a single rat and expressed as a percentage of maximum response in each
region. B, approximate path (dashed lines) of the stimulating electrode for the measurements shown
in A. Diagram modified from the atlas of Paxinos & Watson (1986) at an anteroposterior location of
-5-60. DTG, dorsal tegmental bundle, SNC, substantia nigra, compact; SNR, substantia nigra,
reticular; VTA, ventral tegmental area. C, mean data from 4 animals recorded in the BAN as a result
of stimulation of the ventral tegmental area-substantia nigra region (VTA/SN) or medial forebrain
bundle (MFB). The S.E.M. is shown for every 8 points. Continuous line shows application of a 60 Hz,
2 s stimulation.
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Figure 5. Comparison of evoked dopamine overflow in the basolateral amygdaloid nucleus
(BAN; A) and the dorsomedial area and tail of the caudate-putamen (OP and CPtft; B)
Continuous lines show application of either 20 or 60 Hz for 6 and 2 s, respectively. Curves are the
mean of data collected in 3 or 4 rats and the S.E.M. is shown every 8 points.
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Figure 6. Fatigue of evoked dopamne overflow
The effects of supraphysiological stimulation on evoked dopamine overflow are compared in the
dorsomedial caudate-putamen (CP; A) and basolateral amygdaloid nucleus (BAN; B). Individual
overflow curves were simultaneously collected in the same rat. The stimulating electrode was placed
in the medial forebrain bundle and electrical stimulation was for 10Os at 60 Hz. El, initiation and
termination of the stimulation. The time scale is the same for A and B and is represented by the
continuous line indicating the duration of the stimulus (10 s). Inset, evoked dopamine overflow in the
amygdalo-striatal transition area (AStr) elicited by a 60 Hz stimulation for 2 s. Curve is the mean of
data collected in 3 or 4 rats and the S.E.M. is shown every 8 points.
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Figure 7. Time-dependent decline in evoked dopamine overflow measured in the basolateral
amygdaloid nucleus after a-methyl-para-tyrosine (acMpT; 200 mg kg) administration
The stimulating electrode was positioned in the medial forebrain bundle. Seven trains of electrical
stimulation (60 Hz, 10 s) were applied 20 min apart. aMpT was injected immediately after data
resulting from the second train were collected (time 0 min). A, individual overflow curves. Curves
were collected in a single rat and stimulation was applied 5 s from the onset of recording. B, average
maximum overflow of dopamine. Values for the maximum overflow of dopamine during stimulation
are averaged from data collected in four rats. Time 0 min is the average of the two control
stimulations prior to the administration of aMpT. Data (0) are expressed as the means + S.E.M. The
continuous line is a single exponential curve with a rate constant of 1-4 h' and an initial
concentration of 1-85 uM.
DISCUSSION
In this study, we establish the in vivo measurement of
evoked extracellular dopamine in the BAN using fast-scan
cyclic voltammetry at carbon-fibre microelectrodes.
Extracellular dopamine in the BAN is identified on the
basis of electrochemical, pharmacological and anatomical
evidence. Background-subtracted cyclic voltammograms
recorded in vivo during medial forebrain bundle stimulation
and the abolishment of evoked overflow after aMpT
administration (Fig. 3) indicate that the evoked species in
the BAN is a catecholamine. The predominant catechol-
amines in the BAN are dopamine and noradrenaline
(Fallon & Ciofi, 1992), present at a ratio of approximately
4:1 (Kilts & Anderson, 1987). Both dopamine and
noradrenaline fibres ascend through the medial forebrain
bundle (Ungerstedt, 1971), and thus the possibility exists
that both pathways could be activated by such a
stimulation. However, the contribution of noradrenaline to
the evoked signal measured in the BAN is small since (1)
the mesencephalic sites which elicit evoked dopamine in
the BAN correspond to sites where dopamine cell bodies or
axons are found, and (2) the striato-amygdaloid sites which
support evoked overflow correspond to the documented
dopamine innervation.
Along the dorsoventral axis of our measurements in the
striato-amygdaloid region, dopamine terminal fields are
heterogeneously distributed with the densest innervations
in the tail of the caudate-putamen and the BAN (Fallon &
Ciofi, 1992). In contrast, the noradrenaline innervation in
the amygdala and amygdalo-striatal transition area is
more uniform and very little noradrenaline is found in the
tail of the caudate-putamen (Kilts & Anderson, 1987;
Fallon & Ciofi, 1992). Thus, the dorsoventral heterogeneity
of evoked overflow in the striato-amygdaloid region (Fig. 2)
corresponds to the dopamine but not the noradrenaline
innervation. Furthermore, no overflow was recorded in the
amygdala below 9 0 DV, where the density of the
noradrenaline innervation is similar to that in the BAN
but the density of the dopamine innervation is much less.
Mesoamygdaloid dopamine neurons originate in the
ventral tegmental area and substantia nigra of the ventral
mesencephalon (Fallon, 1988). Electrical stimulation of this
region elicits overflow in the BAN, which has similar
characteristics to overflow evoked by stimulation of the
medial forebrain bundle (Fig. 4). The tips of the bipolar
stimulating electrode are separated sufficiently (1 mm) to
stimulate dopamine neurons in both the ventral tegmental
area and substantia nigra (Garris et at. 1993). No overflow is
recorded in the BAN when the stimulating electrode was
positioned in the dorsal tegmental bundle, which contains
ascending noradrenaline neurons originating from the
locus coeruleus (Ungerstedt, 1971). Taken together, the
results strongly suggest that dopamine is the evoked
species measured in the BAN.
Earlier studies measuring extracellular dopamine levels
in vivo in the amygdala have employed push-pull
cannulae (Leviel, Charriere, Fayada & Guibert, 1986; Dietl,
J. Physiol. 478.22946
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1987) and, more recently, microdialysis (Ishida, Hashiguchi,
Yamamoto, Hashitani, Ikeda & Nishino, 1991). A technical
limitation is that the two amygdaloid nuclei containing the
most dense terminal fields for dopamine, the BAN and
central amygdaloid nucleus, are quite small relative to the
size of these probes. In fact, push-pull cannulae cannot be
directly inserted in the central amygdaloid nucleus
without causing severe damage. By comparison, the tip of
the carbon-fibre microelectrode used in this study has a
maximal dimension of 40 ,um and permits sampling in
extracellular fluid with much improved spatial resolution.
For example, within a dorsoventral distance of 1-2 mm in
the region adjoining the tail of the caudate-putamen,
amygdalo-striatal transition area and BAN, three distinct
overflow curves can be observed (Figs 2, 5 and 6). These
curves underscore the importance of making spatially
resolved measurements of extracellular dopamine levels in
the striato-amygdaloid region.
Differences in the regulation of extracellular dopamine
levels in the BAN and caudate-putamen are suggested by
the significantly different dynamics of the overflow curves
recorded in the two regions (Figs 2 and 5). For example, the
time for evoked signals to return to baseline is considerably
different. In the caudate-putamen, the clearance of extra-
cellular dopamine post-stimulation is the result of cellular
uptake (Ewing & Wightman, 1984). Recently, we have
kinetically analysed the clearance portion of overflow curves
and determined that dopamine uptake is 10 times less in
the BAN than in the caudate-putamen when rates are
normalized to the sixfold difference in dopamine terminal
density between the two regions (Garris & Wightman, 1994).
The uptake of dopamine represents the major factor
terminating dopamine neurotransmission in the
telencephalon (Horn, 1990). Since uptake determines the
half-life and thus the diffusion distance of evoked
dopamine (Kawagoe, Garris, Wiedmann & Wightman,
1992), the low rate in the BAN suggests that dopamine may
be playing a role more like a neuromodulator than a neuro-
transmitter. The connection between dopamine uptake
and the nature of dopaminergic transmission is evident in
the hypothalmo-pituitary axis where dopamine acts as a
neurohormone and only low-affinity dopamine uptake has
been demonstrated (Demarest & Moore, 1979). The
biochemistry of the dopamine uptake transporter has
recently been revealed and differences in post-translational
modification may be responsible for the observed regional
differences in dopamine uptake. Although only a single
gene for the transporter has been identified in the ventral
mesencephalon (Kilty, Lorang & Amara, 1991), the
transporter in the nucleus accumbens exhibits a higher
molecular weight than that in the caudate-putamen,
which appears to be due to different degrees of glycosylation
(Lew, Patel, Vaughan, Wilson & Kuhar, 1992).
The determination of release rates from overflow curves
is more difficult because both release and uptake occur
extracellular dopamine levels (Figs 2 and 5) coupled with
the slower rate of dopamine uptake suggests that absolute
release rates for dopamine are lower than in the
caudate-putamen. Indeed, using a mathematical model to
tease apart release and uptake components of overflow
(Wightman et al. 1988), we found this to be the case (Garris
& Wightman, 1994). These differences are probably not an
artifact of the stimulation since maximum overflow is
achieved in both the BAN and caudate-putamen at the
same stimulating electrode location (Fig. 3) and overflow is
optimized to this position. However, dopamine release,
when normalized to tissue dopamine content, was identical
in both regions. The 'normal' release rate combined with
the unusually low uptake rate in the BAN is reflected in
the curves elicited by 20 Hz (Fig. 5). In the
caudate-putamen, extracellular dopamine levels reach
steady state due to a balance between release and uptake
(Wightman et al. 1988). In contrast, dopamine levels
continue to rise during the stimulation in the BAN because
release is greater than uptake.
The existing evidence suggests that mesoamygdaloid
and mesoprefrontal cortical dopamine neurons have
similar functional characteristics which are unique
compared with mesostriatal dopamine neurons (Bannon &
Roth, 1983; Kilts et al. 1988). However, our recent work
demonstrates that relative dopamine release rates are
tenfold higher in the medial prefrontal cortex compared
with the BAN or striatum (Garris & Wightman, 1994). We
were most intrigued by this finding given that the highest
turnover rates for tissue dopamine in the telencephalon are
found in the amygdala, including the BAN, and medial
prefrontal cortex (Bannon, Bunney & Roth, 1981; Kilts &
Anderson, 1987), and that the high turnover rate in the
medial prefrontal cortex has been attributed to high
dopamine release rates in situ (Bannon & Roth, 1983). We
pursued this issue by examining characteristics which
reflect the 'availability' of neuronal stores of dopamine for
evoked release in the BAN and which have previously been
shown to be very different in the striatum and medial
prefrontal cortex (Garris et al. 1993).
A decline in the dopamine release rate during long
stimulation trains (10 s) at high frequency (60-100 Hz) is
observed in the striatum (Michael, Ikeda & Justice, 1987)
but not in the medial prefrontal cortex (Garris et al. 1993).
As shown in Fig. 6, dopamine release in the BAN during
supraphysiological stimulation more resembles that in the
striatum. As a rough estimate of fatigue, the ratio of the
linear release rates during the last and first half of the
stimulation was calculated. This ratio was 0 3 in the BAN,
which is similar to the caudate-putamen but considerably
less than the medial prefrontal cortex (0-4 and 10,
respectively; Garris et al. 1993). The results suggest that
releasable dopamine stores in the BAN are being depleted
during the long stimulation trains. The observations in the
medial prefrontal cortex and striatum are in excellent
during the stimulus train. In the BAN, the slower rise in
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agreement with in vitro studies examining the fractional
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efflux of radiolabelled dopamine (Hoffmann, Talmaciu,
Ferro & Cubeddu, 1988). Unfortunately, comparable results
are not currently available in the BAN in vitro to
corroborate our in vivo findings.
The decay in evoked dopamine overflow following
synthesis inhibition with aMpT probes the dynamics of
intraneuronal dopamine pools (Ewing, Bigelow &
Wightman, 1983). The rate constant for the turnover of the
releasable pool of dopamine is approximately 1P7 h1 in the
striatum (Wood & Altar, 1988; Garris et al. 1993) and 1P4 h'
in the BAN (Fig. 7). Both values are higher than in the
medial prefrontal cortex (0O8 h1; Garris et al. 1993). A large
dissimilarity between the turnover rate constants for
striatal tissue (0 4 h'; Bannon et al. 1981; Kilts &
Anderson, 1987) and releasable dopamine has been observed
(Garris et al. 1993) and indicates that the transfer between
intraneuronal storage and releasable pools for dopamine is
very slow. In contrast, both turnover rate constants are
similar in the medial prefrontal cortex (tissue rate constant
is 07 h-'; Bannon et al. 1981), which has been interpreted to
be the result of labile storage and releasable pools of
dopamine (Garris et al. 1993). While the rate constant for
evoked dopamine overflow in the BAN (1P4 h1) is greater
than for the aMpT-induced decrease in tissue levels of
dopamine (09 h'; Kilts & Anderson, 1987), this difference
is less than that found in the striatum.
These results demonstrate that mesoamygdaloid dopamine
neurons exhibit similar characteristics for dopamine release
to mesostriatal but not mesoprefrontal cortical dopamine
neurons. However, the dynamics of the intraneuronal
dopamine pools appear very different and mesoamygdaloid
dopamine neurons share with mesoprefrontal cortical
dopamine neurons the ability to use a greater percentage of
intraneuronal dopamine stores for release. In addition, the
high turnover rates of tissue dopamine in the BAN and
medial prefrontal cortex must have different origins. One
possibility is that the high rate in the medial prefrontal
cortex is related to the high dopamine release rate and that
the high rate in the BAN is related to the usually low rate
of dopamine uptake observed in the BAN, which makes
recapture of release dopamine less likely and thus less
conserved.
In conclusion, the results support the notion that
subsets of the mesotelencephalic dopamine system are
quite heterogeneous. Differences in evoked extracellular
dopamine, as measured by fast-scan cyclic voltammetry
at carbon-fibre microelectrodes, were pronounced in the
striato-amygdaloid region. This observation was facilitated
by the ability to compare overflow directly using a single
electrode in dopamine terminal fields of the tail of the
caudate-putamen, amygdalo-striatal transition area and
BAN lying along the same dorsoventral axis. Since
dopamine in the telencephalon subserves dissimilar
functions (Le Moal & Simon, 1991), the relationship between
the nature of extracellular dopamine regulation and
dopamine function should be pursued.
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